Communications in Humanities Research ISSN: 2753-7072
Home> Volumes> Volume CHR Vol.51> Article
Research Article

Mortality Rates in Individuals with Schizophrenia: Evaluation of Contributing Factors and Intervention Strategies

Chieh-an TaiUniversity of Exeter*

* Corresponding author: [email protected]

Abstract

Schizophrenia is a serious mental illness with a significantly higher mortality rate than the general population. People with schizophrenia face a greater risk of early death due to comorbidities, lifestyle choices, and side effects from antipsychotic medications. This research explores the factors contributing to this increased risk, emphasizing the impact of cardiovascular disease, diabetes, and respiratory conditions, all worsened by unhealthy lifestyles such as smoking, poor dietary habits, and lack of exercies. The study also examines the role of antipsychotics, particularly second-generation antipsychotics, in increasing metabolic and cardiovascular risk. In addition, socioeconomic status (SES) is recognised as a key social determinant, as people with lower SES experience greater health disparities and less access to healthcare. This study evaluated existing intervention strategies, such as integrated care models and lifestyle interventions, and assessed their effectiveness in reducing mortality risk. By addressing these factors, this study aims to inform healthcare policy and improve care and life expectancy for individuals with schizophrenia.

Keywords: Schizophrenia; Standard Mortality Ratios (SMRs); contributing factors; intervention strategies.
Published: November 26, 2024
DOI: 10.54254/2753-7064/51/20242490
Volume: CHR Vol.51
pp. 118-122
Download PDF

References

  1. Palmer B.A., Pankratz V.S., Bostwick J.M. The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry. 2005;62(3):247-253.
  2. Brown S. Excess mortality of schizophrenia: a meta-analysis. Br J Psychiatry. 1997;171:502-508.
  3. Saha, S., Chant, D., & McGrath, J. (2007). A systematic review of mortality in schizophrenia. Archives of General Psychiatry, 64(10), 1123. https://doi.org/10.1001/archpsyc.64.10.1123
  4. Osborn, D. P., Levy, G., Nazareth, I., Petersen, I., Islam, A., & King, M. B. (2007). Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom’s General Practice Research Database. Archives of General Psychiatry, 64(2), 242. https://doi.org/10.1001/archpsyc.64.2.242
  5. Osborn, D. P. J., Limburg, H., Walters, K., Petersen, I., King, M., Green, J., Watson, J., & Nazareth, I. (2013). Relative incidence of common cancers in people with severe mental illness. Cohort Study in the United Kingdom Thin Primary Care Database. Schizophrenia Research, 143(1), 44–49. https://doi.org/10.1016/j.schres.2012.11.009
  6. McGrath J., Saha S., Welham J., El Saadi O., MacCauley C., et al. (2004) A systematic review of the incidence of schizophrenia: The distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med 2: 13.
  7. Murray C.J., Lopez A.D. (1996) The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Boston: Harvard School of Public Health. pp.990.
  8. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders: DSM-IV, 4th ed. Washington (DC): American Psychiatric Association, pp.886.
  9. Goldner E.M., Hsu L., Waraich P., Somers J.M. (2002) Prevalence and incidence studies of schizophrenic disorders: A systematic review of the literature. Can J Psychiatry 47: 833–843.
  10. Saha, S., Chant, D., Welham, J., & McGrath, J. (2005). A systematic review of the prevalence of schizophrenia. PLoS medicine, 2(5), e141.
  11. Tsuang, M. T., & Woolson, R. F. (1977). Mortality in patients with schizophrenia, mania, depression and surgical conditions: a comparison with general population mortality. The British Journal of Psychiatry, 130(2), 162-166.
  12. Nishanth, K. N., Chadda, R. K., Sood, M., Biswas, A., & Lakshmy, R. (2017). Physical comorbidity in schizophrenia & its correlates. Indian Journal of Medical Research, 146(2), 281-284.
  13. Brown, S., Birtwistle, J., Roe, L., & Thompson, C. (1999). The unhealthy lifestyle of people with schizophrenia. Psychological medicine, 29(3), 697-701.
  14. Lally, J., & MacCabe, J. H. (2015). Antipsychotic medication in schizophrenia: a review. British medical bulletin, 114(1), 169-179.
  15. Goff, D. C., Falkai, P., Fleischhacker, W. W., Girgis, R. R., Kahn, R. M., Uchida, H., ... & Lieberman, J. A. (2017). The long-term effects of antipsychotic medication on clinical course in schizophrenia. American Journal of Psychiatry, 174(9), 840-849.
  16. Haddad, P. M., Brain, C., & Scott, J. (2014). Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient related outcome measures, 43-62.
  17. Link, B. G., Dohrenwend, B. P., & Skodol, A. E. (1986). Socio-economic status and schizophrenia: Noisome occupational characteristics as a risk factor. American Sociological Review, 242-258.